COMMUNIQUÉ DE PRESSE publié le 13/04/2023 à 17:40, il y a 3 années 3 mois INFICON to Publish its First Quarter 2023 Results on Wednesday, April 26, 2023
COMMUNIQUÉ DE PRESSE publié le 30/03/2023 à 17:40, il y a 3 années 3 mois INFICON: AGM approves all motions as proposed by the Board of Directors
COMMUNIQUÉ DE PRESSE publié le 02/03/2023 à 07:01, il y a 3 années 4 mois INFICON with record-high results and mostly optimistic outlook
COMMUNIQUÉ DE PRESSE publié le 20/02/2023 à 18:00, il y a 3 années 5 mois Invitation to the INFICON Media/Analyst Conference Presentation of Q4 2022 and full year 2022 results
COMMUNIQUÉ DE PRESSE publié le 13/01/2023 à 07:00, il y a 3 années 6 mois INFICON: Preliminary Year-End 2022 Results; Communication Calendar 2023
Publié le 22/07/2026 à 18:19, il y a 7 heures 53 minutes Covivio place avec succès 500 M€ d’obligations vertes à 7 ans
Publié le 22/07/2026 à 18:19, il y a 7 heures 53 minutes Covivio successfully places €500 million of 7-year European Green Bonds
Publié le 22/07/2026 à 17:45, il y a 8 heures 27 minutes Groupe CRIT : 2026 first half revenue: €1.67 billion (+2.3% on an organic basis).
Publié le 22/07/2026 à 17:45, il y a 8 heures 27 minutes Groupe CRIT : Chiffre d’affaires du 1er semestre 2026 : 1,67 Md€ (+2,3% en organique).
Publié le 22/07/2026 à 17:40, il y a 8 heures 32 minutes Report on share repurchases from 15 to 21 July 2026
Publié le 22/07/2026 à 15:00, il y a 11 heures 12 minutes Karbon-X Secures Technical Advisory Engagement for Nature-Based Carbon Project in Libya
Publié le 22/07/2026 à 15:00, il y a 11 heures 12 minutes Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF) Due to Microvillus Inclusion Disease (MVID)
Publié le 22/07/2026 à 14:35, il y a 11 heures 37 minutes Wi2Wi Reports Significant Manufacturing Yield Improvement in Q2 2026
Publié le 22/07/2026 à 14:30, il y a 11 heures 42 minutes As Ebola Death Toll Surpasses 930 Within Two Months, NanoViricides Has Applied to the DR Congo Regulatory Agency for Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola
Publié le 23/07/2026 à 02:05, il y a 6 minutes JINRO Unveils First Global Campaign "My Favorite JINRO" with V of BTS
Publié le 22/07/2026 à 23:58, il y a 2 heures 14 minutes EQS-Adhoc: Deutsche Rohstoff AG: Increase in 2026 Guidance: EBITDA of approximately EUR 365 million expected
Publié le 22/07/2026 à 22:20, il y a 3 heures 51 minutes Quantinuum Appoints Chief Legal Officer and Chief People Officer
Publié le 22/07/2026 à 21:01, il y a 5 heures 10 minutes EQS-Adhoc: Correction of a release from 22/07/2026, 20:08 CET/CEST - FUCHS SE: Preliminary results for the first half of the year ahead of expectations and increase in the EBIT forecast for 2026